Monday, December 30, 2013

Biobetters: Challenges and Opportunities

The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biobetters are the next big opportunity for biopharma to benefit from this growth. This podcast will explore the regulatory and scientific considerations for the development of biobetters.

Thought Leader: Hazel Gorham, Ph.D., Director, Biosimilars Development, PRA

Play podcast

How Working Together Effectively on a Clinical Trial is Like Doing a Successful Skydive

In this episode, Ms. Ruby discusses how clinical trials are like skydiving, what some of the key challenges are in clinical trials, solving unexpected challenges, and creating a productive and collaborative relationship between CROs and sponsors.

Thought Leader: Barbara Ruby, Project Director, SynteractHCR, Inc.

Play podcast

Risk-based monitoring (RBM): A shift in paradigm from the traditional experimental design

In this episode, Mr. Penniston and Ms. Taber talk about risk-based monitoring what it is, why it's important, what are the components, what skill sets or tools are necessary, and the challenges and opportunities related to risk-based monitoring.

Thought Leaders: Mark Penniston, Senior Vice President and General Manager, Clinical Analytics, Theorem Clinical Research and Alison Taber, Vice President of Global Data Management, Theorem Clinical Research

Thursday, November 14, 2013

Creating Great Multichannel CRM Experiences: Advice from a 28-year Pharma Expert

In this episode, Mr. Lammers talks about using a multichannel business strategy in life science companies. He defines the multichannel approach, covers the core challenges, offers his review on Pharma's adoption of multichannel, and provides advice for commercial leaders.

Thought Leader: Peter Lammers, VP, Strategy, Veeva Systems

Play podcast

Building Better Medication Adherence Models to Improve Health Outcomes

In this episode, Mr. Dockery covers several issues related to patient adherence, including using Big Data to predict patient behavior and improve adherence in a patient population, as well as how to accurately measure adherence rates.

Thought Leader: Jim Dockery, Executive Director, Market Data Insights and Innovation, Adheris

Play podcast

Wednesday, November 13, 2013

Unlocking the Power of Strategic Workforce Planning

In this episode, we discuss the challenges in pharma regarding workforce management, the growing trend of strategic workforce planning, and how this phenomenon will continue to evolve over the next 5 years.

Thought Leader: Mark Lanfear, Global Practice Leader, Americas Scientific Product Group, Kelly Services, Inc.

Play podcast

Monday, September 30, 2013

Change Agents + Team Coaching = Transformation from the Inside Out at Sanofi

In this episode, Craig Flanagan and DJ Mitsch talk about a major culture change at Sanofi Pharmaceuticals North America: how they designed it, implemented it, what the results were, and the future of this significant undertaking. This podcast will be of great interest to anyone at a large company who is considering or has decided to implement a powerful culture change.

Thought Leaders: Darelyn "DJ" Mitsch, President, The Pyramid Resource Group, Inc. and Craig Flanagan, VP, Business Excellence and Commercial Capabilities, sanofi-aventis

Play podcast

Wednesday, August 28, 2013

Risk-Based Monitoring for Late Phase: Implementation Strategies

In this episode, Ms. Harrison discusses the past, present, and future of Risk-based Monitoring. She also covers challenges and solutions, as well as a real-life example of RBM in a clinical study.

Thought Leader: Maria Harrison, Vice President, Late Phase Services, PRA

Friday, May 31, 2013

Disruptive Innovation in R&D Processes

In this episode, Dr. Davis discusses open innovation, nontraditional partnerships, collaboration, new technologies, and the future of R&D.

Thought Leader: Dr. Hugh Davis, VP and head of Biologics Clinical Pharmacology Biotechnology Center of Excellence, Janssen Research and Development

Thursday, May 30, 2013

Immersive Learning: What You Need to Know to Build Faster, Smarter Commercial Teams

In this episode, Mr. O'Grady speaks about immersive learning, what it is, and how it is the best choice for many types of mission-critical training.

Thought Leader: Garry O'Grady, SVP and General Manager, Pharmaceutical Institute

Tuesday, April 30, 2013

Developing Robust Potency Assays for Validation

In this episode, Peter Wunderli, Ph.D., discusses PPD's recent laboratory facility expansion, outlines challenges and critical factors in cell-based bio bioassay product development, talks about disease states suitable for this type of technology, and finally, takes a look into the future of cell-based assays.

Thought Leader: Peter Wunderli, Ph.D., Associate Director, Biopharmaceutical Services at PPD

What is Creativity?

In this episode, Anthony Rotolo talks about creativity in the health and wellness space. We cover the importance of creativity in advertising, how to be creative, and, when used properly, how creativity influences behavior change.

Thought Leader: Anthony Rotolo, Chief Creative Officer, TRUE Health + Wellness

Monday, April 22, 2013

Value of a Credential in the Medical Publications Profession

In this episode, Stacy Simpson Logan talks about the value of obtaining a CMPP credential for employees and employers as well as the future of the CMPP program. CMPP stands for Certified Medical Publication Professional and is administered by ISMPP, the International Society for Medication Publication Professionals.

Thought Leader: Stacy Simpson Logan, Chair, CMPP Board of Trustees President, Waterfall Consulting

Friday, March 29, 2013

What Do Mick Jagger, Diabetes, Heart Disease, and Cancer Have in Common?

In this episode, Ms. Hammond talks about our aging society and how the industry needs to address its therapies to reflect the differences in age groups, including the old, and the very old.

Date Posted: 03/28/2013  Size: 9.6MB  Length: 00:20:52  
Thought Leader: Melissa Hammond MSN, GNP, Managing Director, Snowfish

Transitioning Clinical Trial Patients to Commercial Supply via Managed Access Programs

This podcast describes how Managed Access Programs can continue treatment access for patients coming out of registration or other clinical trials who need to transition to commercial supply.

Thought Leaders: Suzanne Gagnon, MD, Chief Medical Officer, Idis, Karen Searle PhD, Study Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development and Michelle Gee, PhD, Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development

Play podcast

Thursday, January 31, 2013

Conducting User Testing to Improve Clinical Trial Technologies

Thought Leader: Joseph Bedford, Ph.D., Director of Marketing, Almac Clinical Technologies

In this episode, we discuss how user testing research improves the clinical trial process for patients, sites, and sponsors.

For more information about Almac Clinical Technologies, visit

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at or call him at (847) 594-0157.